跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
普泽力 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Darunavir and Cobicistat Tablets
Approved
化学药品
Darunavir and Cobicistat Tablets
Janssen-Cilag International NV
🇨🇳 National Medical Products Administration
Approval Date
Jun 14, 2023
Approval ID
8TELEvrg4Fj
Company
Janssen-Cilag International NV
Type
化学药品
Approval Details
Approval Id
8TELEvrg4Fj
Approval Number
国药准字HJ20180030
Generic Name
达芦那韦考比司他片
Generic Name En
Darunavir and Cobicistat Tablets
Trade Name
普泽力
Drug Type
化学药品
Dosage Form
片剂
Strength
每片含800mg达芦那韦(相当于867.28mg达芦那韦乙醇合物)和150mg考比司他
Reg Date
2023-06-14
Expired Date
2028-06-13
Company Name
Janssen-Cilag International NV
Company Address
Turnhoutseweg 30, B-2340 Beerse, Belgium
Production Company Name
Janssen Ortho, Llc
Production Company Address
State Road 933, KM 0.1, Mamey Ward, Gurabo, Puerto Rico, 00778, United States of America
Company Detail Path
/organization/janssen-cilag-international-nv
Production Company Detail Path
/organization/janssen-ortho-llc-san-juan-puerto-rico-united-states
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 14, 2023
Approval ID
8TELEvrg4Fj
Type
化学药品
Back to NMPA Approvals